Upperton Limited

POWER SEARCH PRICING

SOLUTIONS

upperton limited Company Information

Company Number

03833301

Next Accounts

20 days late

Directors

Richard Johnson

Nicola Whitfield

View All

Shareholders

crocus bidco limited

Group Structure

View All

Industry

Research and experimental development on biotechnology

Registered Address

albert einstein centre, nottingham science & technology, nottingham, NG7 2TN

Website

www.upperton.com

upperton limited Estimated Valuation

£32.2m

Pomanda estimates the enterprise value of UPPERTON LIMITED at £32.2m based on an EBITDA of £5m and a 6.4x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Upperton Limited is a live company located in nottingham, NG7 2TN with a Companies House number of 03833301. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in August 1999, it's largest shareholder is crocus bidco limited with a 100% stake. Upperton Limited is a mature, mid sized company, Pomanda has estimated its turnover at £9.6m with rapid growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Upperton Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 2 areas for improvement. Company Health Check FAQs

Health Rating4.5out of 5

5 Strong

4 Regular

2 Weak

Size

annual sales of £9.6m, make it larger than the average company (£3.1m)

Growth

3 year (CAGR) sales growth of 61%, show it is growing at a faster rate (12%)

EXPORT

Upperton Limited's latest turnover from June 2023 is estimated at £9.6 million and the company has net assets of £9.5 million. According to their latest financial statements, Upperton Limited has 69 employees and maintains cash reserves of £9.1 million as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Aug 2019	Aug 2018	Aug 2017	Aug 2016	Aug 2015	Aug 2014	Aug 2013	Aug 2012	Aug 2011	Aug 2010	Aug 2009
Turnover	9,575,218	5,745,915	2,712,313	2,273,408	1,484,923	1,292,796	1,722,186	1,163,828	1,077,799	386,834	367,616	196,823	98,332	213,950
Other Income Or Grants
Cost Of Sales	4,347,895	2,793,314	1,331,852	1,115,248	717,198	628,263	821,666	605,756	562,409	196,380	201,031	105,071	48,397	96,121
Gross Profit	5,227,323	2,952,601	1,380,461	1,158,160	767,725	664,533	900,520	558,072	515,390	190,453	166,585	91,753	49,935	117,829
Admin Expenses	582,747	-436,963	461,367	1,106,787	1,534,085	16,306	-467,755	-257,398	380,680	96,936	110,931	53,260	75,131	106,980	-93,241
Operating Profit	4,644,576	3,389,564	919,094	51,373	-766,360	648,227	1,368,275	815,470	134,710	93,517	55,654	38,493	-25,196	10,849	93,241
Interest Payable
Interest Receivable	667,202	124,567	2,083	1,886	17,833	18,168	4,004	2,086	1,858	1,083	1,148	774	359	408	201
Pre-Tax Profit	5,311,779	3,514,131	921,177	53,259	-748,527	666,395	1,372,279	817,556	136,568	94,600	56,801	39,267	-24,837	11,257	93,442
Tax	-1,327,945	-667,685	-175,024	-10,119		-126,615	-260,733	-163,511	-27,313	-19,866	-13,064	-9,424		-3,152	-26,164
Profit After Tax	3,983,834	2,846,446	746,153	43,140	-748,527	539,780	1,111,546	654,045	109,254	74,734	43,737	29,843	-24,837	8,105	67,278
Dividends Paid
Retained Profit	3,983,834	2,846,446	746,153	43,140	-748,527	539,780	1,111,546	654,045	109,254	74,734	43,737	29,843	-24,837	8,105	67,278
Employee Costs	5,192,940	2,272,874	2,162,633	1,959,572	1,343,813	1,018,209	874,794	683,337	712,073	266,407	204,219	155,450	106,425	100,936
Number Of Employees	69	31	31	29	20	16	16	12	13	5	4	3	2	2
EBITDA*	5,030,520	3,389,564	1,159,395	293,634	-637,693	778,001	1,477,195	863,675	160,436	110,586	62,647	45,963	-16,332	17,322	105,833

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Aug 2019	Aug 2018	Aug 2017	Aug 2016	Aug 2015	Aug 2014	Aug 2013	Aug 2012	Aug 2011	Aug 2010	Aug 2009
Tangible Assets	16,587,870	1,340,020	720,904	726,786	386,001	389,322	326,773	146,720	77,180	51,225	20,975	22,409	26,592	26,106	24,277
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets	16,587,870	1,340,020	720,904	726,786	386,001	389,322	326,773	146,720	77,180	51,225	20,975	22,409	26,592	26,106	24,277
Stock & work in progress
Trade Debtors	1,377,148	1,449,368	420,053	217,206			294,332	154,296	156,110	53,078	46,439	3,571	19,199	36,931	20,337
Group Debtors
Misc Debtors	2,550,019	388,855			146,422	47,719	2,145	6,573
Cash	9,115,099	17,572,999	2,357,715	1,807,333	1,964,991	2,790,541	2,054,362	1,149,180	519,817	223,264	209,901	249,114	60,543	83,017	80,223
misc current assets
total current assets	13,042,266	19,411,222	2,777,768	2,024,539	2,111,413	2,838,260	2,350,839	1,310,049	675,927	276,342	256,340	252,685	79,742	119,948	100,560
total assets	29,630,136	20,751,242	3,498,672	2,751,325	2,497,414	3,227,582	2,677,612	1,456,769	753,107	327,567	277,315	275,094	106,334	146,054	124,837
Bank overdraft
Bank loan
Trade Creditors	5,093,758	241,637	413,222	401,695	11,098	50,378	506,952	416,614	380,981	77,074	101,864	143,681	2,426	17,444	5,030
Group/Directors Accounts	13,951,659	13,811,978			368,568	168,715
other short term finances
hp & lease commitments	105,329	81,778	102,098
other current liabilities	697,177	751,527			154,264	283,621
total current liabilities	19,847,923	14,886,920	515,320	401,695	533,930	502,714	506,952	416,614	380,981	77,074	101,864	143,681	2,426	17,444	5,030
loans
hp & lease commitments	98,613	214,822	180,298
Accruals and Deferred Income
other liabilities				262,519
provisions	150,067	99,801	99,801	130,011	49,524	62,381	47,953	28,994	15,010	2,631	2,323	2,022	4,360	4,225	3,527
total long term liabilities	248,680	314,623	280,099	392,530	49,524	62,381	47,953	28,994	15,010	2,631	2,323	2,022	4,360	4,225	3,527
total liabilities	20,096,603	15,201,543	795,419	794,225	583,454	565,095	554,905	445,608	395,991	79,705	104,187	145,703	6,786	21,669	8,557
net assets	9,533,533	5,549,699	2,703,253	1,957,100	1,913,960	2,662,487	2,122,707	1,011,161	357,116	247,862	173,128	129,391	99,548	124,385	116,280
total shareholders funds	9,533,533	5,549,699	2,703,253	1,957,100	1,913,960	2,662,487	2,122,707	1,011,161	357,116	247,862	173,128	129,391	99,548	124,385	116,280

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Aug 2019	Aug 2018	Aug 2017	Aug 2016	Aug 2015	Aug 2014	Aug 2013	Aug 2012	Aug 2011	Aug 2010	Aug 2009
Operating Activities
Operating Profit	4,644,576	3,389,564	919,094	51,373	-766,360	648,227	1,368,275	815,470	134,710	93,517	55,654	38,493	-25,196	10,849	93,241
Depreciation	385,944		240,301	242,261	128,667	129,774	108,920	48,205	25,726	17,069	6,993	7,470	8,864	6,473	8,092
Amortisation															4,500
Tax	-1,327,945	-667,685	-175,024	-10,119		-126,615	-260,733	-163,511	-27,313	-19,866	-13,064	-9,424		-3,152	-26,164
Stock
Debtors	2,088,944	1,418,170	202,847	70,784	98,703	-248,758	135,608	4,759	103,032	6,639	42,868	-15,628	-17,732	16,594	20,337
Creditors	4,852,121	-171,585	11,527	390,597	-39,280	-456,574	90,338	35,633	303,907	-24,790	-41,817	141,255	-15,018	12,414	5,030
Accruals and Deferred Income	-54,350	751,527		-154,264	-129,357	283,621
Deferred Taxes & Provisions	50,266		-30,210	80,487	-12,857	14,428	18,959	13,984	12,379	308	301	-2,338	135	698	3,527
Cash flow from operations	6,461,668	1,883,651	762,841	529,551	-917,890	741,619	1,190,151	745,022	346,377	59,599	-34,801	191,084	-13,483	10,688	67,889
Investing Activities
capital expenditure	-15,633,794	-619,116	-234,419	-583,046	-125,346	-192,323	-288,973	-117,745	-51,681	-47,319	-5,559	-3,287	-9,350	-8,302	-36,869
Change in Investments
cash flow from investments	-15,633,794	-619,116	-234,419	-583,046	-125,346	-192,323	-288,973	-117,745	-51,681	-47,319	-5,559	-3,287	-9,350	-8,302	-36,869
Financing Activities
Bank loans
Group/Directors Accounts	139,681	13,811,978		-368,568	199,853	168,715
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments	-92,658	14,204	282,396
other long term liabilities			-262,519	262,519
share issue															49,002
interest	667,202	124,567	2,083	1,886	17,833	18,168	4,004	2,086	1,858	1,083	1,148	774	359	408	201
cash flow from financing	714,225	13,950,749	21,960	-104,163	217,686	186,883	4,004	2,086	1,858	1,083	1,148	774	359	408	49,203
cash and cash equivalents
cash	-8,457,900	15,215,284	550,382	-157,658	-825,550	736,179	905,182	629,363	296,553	13,363	-39,213	188,571	-22,474	2,794	80,223
overdraft
change in cash	-8,457,900	15,215,284	550,382	-157,658	-825,550	736,179	905,182	629,363	296,553	13,363	-39,213	188,571	-22,474	2,794	80,223

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for upperton limited. Get real-time insights into upperton limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for upperton limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in NG7 area or any other competitors across 12 key performance metrics.

UPPERTON LIMITED group structure

Upperton Limited has no subsidiary companies.

Ultimate parent company

CROCUS TOPCO LIMITED

14025565

CROCUS BIDCO LIMITED

14027934

2 parents

UPPERTON LIMITED

03833301

UPPERTON LIMITED Shareholders

crocus bidco limited

100%

Upperton Limited currently has 3 directors. The longest serving directors include Dr Richard Johnson (Aug 1999) and Mrs Nicola Whitfield (Apr 2022).

officer	country	age	start	end	role
Dr Richard Johnson	United Kingdom	64 years	Aug 1999	-	Director
Mrs Nicola Whitfield	United Kingdom	54 years	Apr 2022	-	Director
Mr Jamie Roberts	England	50 years	Aug 2022	-	Director

P&L

June 2023

turnover

9.6m

+67%

operating profit

4.6m

gross margin

54.6%

+6.24%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

June 2023

net assets

9.5m

+0.72%

total assets

29.6m

+0.43%

cash

9.1m

-0.48%

net assets

Total assets minus all liabilities

Similar Companies

john mcnamara consulting limited

3.5

abpharm analytical consultancy limited

3.5

avacta life sciences limited

bh clinical services limited

4.5

morphogen-ix limited

2.5

company number

03833301

Type

Private limited with Share Capital

industry

72110 - Research and experimental development on biotechnology

incorporation date

August 1999

ultimate parent company

CROCUS TOPCO LIMITED

previous names

N/A

address

albert einstein centre, nottingham science & technology, nottingham, NG7 2TN

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to upperton limited.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for UPPERTON LIMITED. This can take several minutes, an email will notify you when this has completed.

upperton limited Company Information

upperton limited Estimated Valuation

upperton limited Estimated Valuation

upperton limited Estimated Valuation

Upperton Limited Overview

Upperton Limited Health Check

UPPERTON LIMITED financials

upperton limited Credit Report and Business Information

Upperton Limited Competitor Analysis

upperton limited Ownership

upperton limited directors

upperton limited company details

upperton limited Charges & Mortgages

upperton limited Capital Raised & Share Issues BETA

upperton limited Companies House Filings - See Documents